Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GT Biopharma (GTBP) Other Non-Current Assets (2017 - 2020)

GT Biopharma (GTBP) has disclosed Other Non-Current Assets for 5 consecutive years, with $12000.0 as the latest value for Q3 2020.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $12000.0 in Q3 2020 year-over-year; TTM through Sep 2020 was $12000.0, a 0.0% change, with the full-year FY2019 number at $12000.0, changed N/A from a year prior.
  • Other Non-Current Assets was $12000.0 for Q3 2020 at GT Biopharma, roughly flat from $12000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $21000.0 in Q3 2018 to a low of $9000.0 in Q4 2017.
  • A 4-year average of $12000.0 and a median of $12000.0 in 2019 define the central range for Other Non-Current Assets.
  • Biggest YoY gain for Other Non-Current Assets was 33.33% in 2019; the steepest drop was 42.86% in 2019.
  • GT Biopharma's Other Non-Current Assets stood at $9000.0 in 2017, then soared by 133.33% to $21000.0 in 2018, then plummeted by 42.86% to $12000.0 in 2019, then changed by 0.0% to $12000.0 in 2020.
  • Per Business Quant, the three most recent readings for GTBP's Other Non-Current Assets are $12000.0 (Q3 2020), $12000.0 (Q2 2020), and $12000.0 (Q1 2020).